Trialbee
PrivateLast Round
Buyout/LBO
Jan 7, 2026
Total Funding Raised
$20.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Trialbee operates in Healthcare & Life Sciences and is based in Malmö. Its latest recorded funding round was a Series B round in April 2020.
Trialbee is a healthcare technology company that provides a patient matching and engagement platform designed to simplify and accelerate clinical research.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trialbee Comparables
Compare Trialbee with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clariness | 84% | |
| Antidote Technologies | 83% | |
| Reify Health | 82% |
For institutional investors. Book with your work email.
Trialbee Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Jan 7, 2026 | ||||
| Series B | Apr 28, 2020 | ||||
| VC Round | Apr 10, 2018 | ||||
| Series A | May 20, 2015 | ||||
| Seed | Dec 5, 2013 | ||||
Pre Seed | Jun 28, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Trialbee Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Varsity Healthcare Partners | Buyout/LBO |
| MTIP | Buyout/LBO, Series B |
| Startupbootcamp | Accelerator |
| Industrifonden | Pre Seed, Buyout/LBO, VC Round, Series B, Seed, Series A |
| Briban Invest | Seed, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 60% MoM, reaching 15.3K.
- Mar 10, 2026
Rick Riegel appointed to Board of Directors.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 9, 2026
Trialbee is set to unveil AI-powered patient screening in its Honey Platform at DPHARM 2026 in Massachusetts on Sep 15th-16th '26, helping identify ineligible candidates earlier and move qualified referrals to research sites faster.
- attends_eventSep 9, 2026
Trialbee is set to present alongside Takeda, showcase AI for clinical sites, and unveil AI-powered patient screening at DPHARM 2026 in Massachusetts on Sep 15-16 '26.
For institutional investors. Book with your work email.
Trialbee Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trialbee's valuation, stock price, and market status.
Is Trialbee a public or private company?
Trialbee is a private company.
What is the current stock price of Trialbee?
Trialbee is a private company, so its shares have no public market price. Caplight tracks Trialbee's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trialbee worth (valuation)?
Valuation information for Trialbee is not publicly available.
Can I buy Trialbee stock?
Trialbee shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trialbee's last funding round?
Trialbee's most recent funding round was Buyout/LBO on January 7, 2026.
Who are the main investors in Trialbee?
Key investors in Trialbee include Varsity Healthcare Partners, MTIP, Industrifonden, Briban Invest.
Will Trialbee IPO soon?
No public IPO plans have been announced for Trialbee.
How can I track Trialbee secondary market activity?
Caplight tracks bids, offers, and trades in Trialbee's shares on secondary markets.